Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Effect of terazosin on tissue vascularity and apoptosis in transitional cell carcinoma of bladder.

Tahmatzopoulos A, Lagrange CA, Zeng L, Mitchell BL, Conner WT, Kyprianou N.

Urology. 2005 May;65(5):1019-23.

2.

Reduction of human prostate tumor vascularity by the alpha1-adrenoceptor antagonist terazosin.

Keledjian K, Borkowski A, Kim G, Isaacs JT, Jacobs SC, Kyprianou N.

Prostate. 2001 Jul 1;48(2):71-8.

PMID:
11433417
3.
4.
5.

Effect of alpha1-adrenoceptor antagonist exposure on prostate cancer incidence: an observational cohort study.

Harris AM, Warner BW, Wilson JM, Becker A, Rowland RG, Conner W, Lane M, Kimbler K, Durbin EB, Baron AT, Kyprianou N.

J Urol. 2007 Nov;178(5):2176-80.

7.

Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.

Mohammed SI, Craig BA, Mutsaers AJ, Glickman NW, Snyder PW, deGortari AE, Schlittler DL, Coffman KT, Bonney PL, Knapp DW.

Mol Cancer Ther. 2003 Feb;2(2):183-8.

8.
9.

Alpha1-adrenoceptor antagonists radiosensitize prostate cancer cells via apoptosis induction.

Cuellar DC, Rhee J, Kyprianou N.

Anticancer Res. 2002 May-Jun;22(3):1673-9.

PMID:
12168853
10.

Effect of combination therapy with a novel bisphosphonate, minodronate (YM529), and docetaxel on a model of bone metastasis by human transitional cell carcinoma.

Inoue K, Karashima T, Fukata S, Nomura A, Kawada C, Kurabayashi A, Furihata M, Ohtsuki Y, Shuin T.

Clin Cancer Res. 2005 Sep 15;11(18):6669-77.

12.
13.

Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression.

Grossfeld GD, Ginsberg DA, Stein JP, Bochner BH, Esrig D, Groshen S, Dunn M, Nichols PW, Taylor CR, Skinner DG, Cote RJ.

J Natl Cancer Inst. 1997 Feb 5;89(3):219-27.

14.

Identification of apoptotic and antiangiogenic activities of terazosin in human prostate cancer and endothelial cells.

Pan SL, Guh JH, Huang YW, Chern JW, Chou JY, Teng CM.

J Urol. 2003 Feb;169(2):724-9.

PMID:
12544352
15.
16.

[Effect of nitric oxide donor and alpha1-receptor antagonist on proliferation/apoptosis of hyperplastic prostatic stromal cells in vitro].

Deng CH, Chen HR, Qiu SP, Liu JZ, Zheng KL, Mei H.

Zhonghua Wai Ke Za Zhi. 2004 Feb 22;42(4):201-4. Chinese.

PMID:
15062034
18.

Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis.

Bochner BH, Cote RJ, Weidner N, Groshen S, Chen SC, Skinner DG, Nichols PW.

J Natl Cancer Inst. 1995 Nov 1;87(21):1603-12.

PMID:
7563203
19.

Multiple factor analysis of metachronous upper urinary tract transitional cell carcinoma after radical cystectomy.

Wang P, Luo JD, Wu WF, Wang S, Cai SL, Shen BH, Shi SF, Wei KX, Zhang ZG, Chen ZD.

Braz J Med Biol Res. 2007 Jul;40(7):979-84.

20.
Items per page

Supplemental Content

Support Center